|Articles|January 1, 2013
Revisiting Clinical Grant Expenditures
Author(s)TTC
TTC
Advertisement
As site costs continue to increase in the more traditional areas for clinical research, a growing number of CRO's and sponsors are using sites in areas such as Latin America, Asia, and Eastern Europe according to GrantPlan. The demand for less expensive markets have increased as sponsors and CRO's reach toward less expensive regions in which to conduct clinical trials. Lower costs will never be the decisive consideration in selecting a site, however, substantial cost differences are becoming more important in the decision making process.
TTC, now a part of IMS, continues to provide annual current global data on the relative costs of clinical grants around the world using the GrantPlan database. The aggregate GrantPlan subscribers conduct nearly 80% of all commercial clinical trials around the world, with each sponsor company and CRO contributing the current costs of each clinical trial.
Mean cost per visit in Phase II-III clinical trials.
This year, the data shows the United States and the United Kingdom continues to be the most expensive countries for clinical grants. With low single digit growth in the established geographies, grant costs seem to have stabilized. Despite the increased demand, the newer geographies have experienced a slight decrease in the costs per visit of approximately 6% in Asia and a minimal increase in Latin America.
—TTC (for more information, please contact help@ttc-llc.com )
Articles in this issue
over 12 years ago
Act coverover 12 years ago
Free-to-Use eLearning Modulesover 12 years ago
Leading Clinical Projectsover 12 years ago
Clinical Trial Management Systems: Here to Stay?over 12 years ago
Business and News Update January 2013over 12 years ago
Revisiting Clinical Grant Expendituresover 12 years ago
Collaboration Key to Modernizing Clinical Trialsover 12 years ago
New Year Challenges and Promises in Europeover 12 years ago
Research Integrityover 12 years ago
EMA Forges Ahead with Data Access Initiativeover 12 years ago
Will CROs Drive Faster Solutions Adoption?over 12 years ago
Applied Clinical Trials Digital Edition - January 2013Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
AstraZeneca’s Baxdrostat Shows Promise in Phase III Trial for Hard-to-Control Hypertension
2
Driving Transformation With a Connected Clinical Platform: 2025 Veeva R&D and Quality Summit Clinical Opening Keynote
3
Promising Trial Data Leads to Breakthrough Designation for Eli Lilly’s Investigational KRAS G12C Inhibitor in Advanced, Metastatic Non-Small Cell Lung Cancer
4
Epkinly Demonstrates Encouraging Efficacy in Phase II Trial for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
5